CAR T Effective as First-Line Therapy for High-Risk Lymphoma Patients

New three-year data from the phase 2 ZUMA-12 trial finds durable responses

FDA Investigating ‘Serious Risk’ of Malignancy After CAR T Therapy

Benefits of the treatment still outweigh its risks, experts say

Bioengineering: A New Frontier in Cancer Research

The launch of Moffitt’s Bioengineering Department brings novel tools to the fight against cancer

Moffitt Study Aims to Improve Personalized Cancer Vaccines

Selection of neoantigen target critical to therapy’s success

New Approach Using mRNA Generates Cellular Immunotherapy Within the Body

In vivo CAR macrophage therapy can be used to treat solid tumors

Are Cellular Therapies the New Frontier in Cancer Treatment?

Moffitt experts discuss the latest in cellular therapy at annual Research Innovation event

The ReMissions Shine Light on Moffitt’s Mission

“We listen to each other, work together and make harmony together.”

Small, Red Bump Led to Melanoma for Teenager

16-year-old has great response to immunotherapy and surgery

Miles for Moffitt Keeps Researchers on Pace to Find New Cancer Treatments

Series of grants brings together top scientists and clinicians to study how lung tumors metabolize nutrients

Endeavor